US Patent Issued to Mallinckrodt Pharmaceuticals Ireland on Nov. 25 for "Compensating for disruptions in breathing gas flow measurement" (Wisconsin Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,757, issued on Nov. 25, was assigned to Mallinckrodt Pharmaceuticals Ireland Ltd. (Dublin).

"Compensating for disruptions in breathing gas flow measurement" was invented by Jaron M. Acker (Madison, Wis.) and Craig R. Tolmie (Stoughton, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure generally relates to systems and methods for delivery of therapeutic gas to patients, using techniques to compensate for disruptions in breathing gas flow measurement, such as when breathing gas flow measurement is unavailable or unreliable. Such techniques include using historical breathing gas flow rate data, such as moving average flow rates...